L&T Technology Services Ltd

Q1 FY24 Earnings Call Analysis

IT - Services

Full Stock Analysis
capex: Yesfundraise: No informationrevenue: Category 4margin: Category 4orderbook: No information
🏗️

capex

Any current/future capex/capital investment/strategic investment?

- Company is focusing on **long-term investments** aligned with their strategy, especially in software-defined products across Industrial and Medical segments. - Investments include **integrated digital platforms** for connected intelligent products and software-defined everything requirements. - **Legacy plant modernization** is a continuous need and a key investment area. - Emphasis on **Digital Twin technologies** and **Asset Healthcare solutions** for predictive-prescriptive analytics in manufacturing and plants. - Investment in **GenAI enabled pluggable modules** for automation and smart PIDs to optimize legacy plants. - Segment heads have identified specific investments to bootstrap growth, focusing on digital manufacturing, virtualization, and cloud-native frameworks. - Additional investment in a **separate cell for cybersecurity**, creating common assets and IP to scale globally. - The new organizational structure and reorganization to **"Go Deeper to Scale"** will entail **front-ended investments in people and technology** starting FY25. - The company is exploring **M&A opportunities** in ISV, MedTech, and Auto segments, aiming for considered acquisitions that add strategic value.
📊

revenue

Future growth expectations in sales/revenue/volumes?

- FY25 revenue growth guidance is 8-10% in USD constant currency, with an aspiration to reach a $1.5 billion run rate by FY25. - Growth is expected to be back-ended in FY25 due to geopolitical uncertainties affecting decision-making in the near term. - Positive growth drivers include: - Mobility: Increased spend in software defined vehicles (SDV), engaging with 8 major OEMs, focusing on experience zones and ADAS. - Sustainability: New spends in Oil & Gas, Chemicals, FMCG; growth in Digital Products, AI, and Digital Manufacturing. - Hi-Tech: Expansion in MedTech, Semiconductors, Hyperscalers, and next-gen communications. - Large deals closed in FY24 included 25 deals over $10M, with 1 $100M deal, indicating strong pipeline. - Continued investment in growth segments like Mobility, Sustainability, and Hi-Tech with a streamlined organizational structure to drive client intimacy and innovation. - Some softness expected in Q1 and Q2 margins, with recovery in H2 FY25.
📈

margin

Future growth expectations in earnings/operating earnings/profits/EPS?

- LTTS expects USD constant currency revenue growth of 8-10% for FY25, with aspirations to reach a $1.5 billion annual run rate. - EBIT margin guidance for FY25 is around 16%, slightly lower than FY24’s 17.1%, due to new investments and geopolitical uncertainties; the company aims to improve margins medium-term. - The company aspires to return to 18% EBIT margin levels by H1 FY26 but expects it will take a few quarters to clarify this. - Profit for FY24 was ₹1,304 crores; strong free cash flow and ROE at 27% suggest healthy profitability. - Margin softness is attributed to investments in people, technology, and new organizational structure focused on Mobility, Sustainability, and Hi-Tech segments. - LTTS targets organic growth of 8-10% CC and is working on M&A opportunities for medium to long-term growth acceleration.
📋

orderbook

Current/ Expected Orderbook/ Pending Orders?

- The transcript does not explicitly state the current or expected order book value. - Management highlighted a strong deal pipeline gradually building up, with large deal wins in Q4 including one $100 million, one $30 million, two $20 million, and two $10 million deals. - A significant empanelment win was secured in the Oil & Gas sector. - Decision-making delays due to geopolitical and economic uncertainties persist, impacting deal closures. - The company remains optimistic about growth opportunities in Mobility, Sustainability, and Hi-Tech segments. - Workshops and leadership elevation indicate strengthening of deal acquisition capabilities. - M&A activity is ongoing, targeting strategic acquisitions in ISV, MedTech, North America, and Auto in Europe, which could contribute to future order growth. - Overall, the company is confident about sustaining an 8-10% revenue growth and reaching a $1.5 billion run rate in FY25 tied to robust order inflow and pipeline.
💰

fundraise

Any current/future new fundraising through debt or equity?

- The transcript does not mention any current or planned fundraising through debt or equity. - The company focuses on strategic investments funded internally, as indicated by cash flow and investment discussions. - Cash and investments remained robust at ₹2,883 crores after paying dividends and acquiring SWC. - Free cash flow hit an all-time high of ₹1,251 crores in FY24, suggesting strong internal funding capability. - Management emphasized considered acquisitions and investments but noted no hasty decisions on funding. - No announcements or indications about raising capital via debt or equity were disclosed during this call.